Cargando…
CORRIGENDUM to “Should patients receive consolidation chemotherapy before reduced intensity allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia in first complete remission?”
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8239966/ https://www.ncbi.nlm.nih.gov/pubmed/34249301 http://dx.doi.org/10.1177/20406207211027370 |
Ejemplares similares
-
Should patients receive consolidation chemotherapy before reduced
intensity allogeneic hematopoietic stem cell transplantation for acute myeloid
leukemia in first complete remission?
por: Byun, Ja Min, et al.
Publicado: (2021) -
Comparison of post-remission strategies in acute myeloid leukemia: Autologous hematopoietic stem cell transplantation versus consolidation chemotherapy
por: Yegin, Zeynep Arzu, et al.
Publicado: (2020) -
Busulfan and melphalan as conditioning regimen for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia in first complete remission
por: Bueno, Nadjanara Dorna, et al.
Publicado: (2011) -
Allogeneic hematopoietic stem cell transplantation for pediatric acute myeloid leukemia in first complete remission: a meta-analysis
por: Masetti, Riccardo, et al.
Publicado: (2022) -
Corrigendum to “Study on the Therapeutic Benefit on Lactoferrin in Patients with Colorectal Cancer Receiving Chemotherapy”
por: Moastafa, Tarek M., et al.
Publicado: (2015)